177 related articles for article (PubMed ID: 8118799)
1. Microsatellite instability in Muir-Torre syndrome.
Honchel R; Halling KC; Schaid DJ; Pittelkow M; Thibodeau SN
Cancer Res; 1994 Mar; 54(5):1159-63. PubMed ID: 8118799
[TBL] [Abstract][Full Text] [Related]
2. Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry.
Ponti G; Losi L; Di Gregorio C; Roncucci L; Pedroni M; Scarselli A; Benatti P; Seidenari S; Pellacani G; Lembo L; Rossi G; Marino M; Lucci-Cordisco E; Ponz de Leon M
Cancer; 2005 Mar; 103(5):1018-25. PubMed ID: 15662714
[TBL] [Abstract][Full Text] [Related]
3. [Clinical follow-up and presence of visceral tumors in 12 patients with sebaceous gland tumors].
Mercader P; García-Melgares ML; Roche E; Sánchez-Carazo JL; Alegre-de Miquel V
Actas Dermosifiliogr; 2008 Sep; 99(7):532-9. PubMed ID: 18682166
[TBL] [Abstract][Full Text] [Related]
4. Widespread microsatellite instability in sebaceous tumours of patients with the Muir-Torre syndrome.
Peris K; Onorati MT; Keller G; Magrini F; Donati P; Muscardin L; Höfler H; Chimenti S
Br J Dermatol; 1997 Sep; 137(3):356-60. PubMed ID: 9349329
[TBL] [Abstract][Full Text] [Related]
5. Muir-Torre syndrome.
Cohen PR; Kohn SR; Davis DA; Kurzrock R
Dermatol Clin; 1995 Jan; 13(1):79-89. PubMed ID: 7712655
[TBL] [Abstract][Full Text] [Related]
6. [Muir-Torre syndrome and familial colorectal cancer: 2 families with molecular genetic analysis].
Doré MX; Dieumegard B; Grandjouan S; Avril MF; Martinet C; Ducreux M; Lasser P; Bressac-de Paillerets B
Ann Dermatol Venereol; 1999; 126(8-9):582-6. PubMed ID: 10530344
[TBL] [Abstract][Full Text] [Related]
7. [Muir-Torre syndrome].
Yoshikawa R; Utsunomiya J
Nihon Rinsho; 1995 Nov; 53(11):2803-6. PubMed ID: 8538048
[TBL] [Abstract][Full Text] [Related]
8. Different phenotypes in Muir-Torre syndrome: clinical and biomolecular characterization in two Italian families.
Ponti G; Ponz de Leon M; Losi L; Di Gregorio C; Benatti P; Pedroni M; Scarselli A; Riegler G; Lembo L; Pellacani G; Seidenari S; Rossi G; Roncucci L
Br J Dermatol; 2005 Jun; 152(6):1335-8. PubMed ID: 15949004
[TBL] [Abstract][Full Text] [Related]
9. Muir-Torre syndrome: clinical features and molecular genetic analysis.
Esche C; Kruse R; Lamberti C; Friedl W; Propping P; Lehmann P; Ruzicka T
Br J Dermatol; 1997 Jun; 136(6):913-7. PubMed ID: 9217825
[TBL] [Abstract][Full Text] [Related]
10. Upper tract urothelial carcinoma: a clinicopathologic study including microsatellite instability analysis.
Blaszyk H; Wang L; Dietmaier W; Hofstädter F; Burgart LJ; Cheville JC; Hartmann A
Mod Pathol; 2002 Aug; 15(8):790-7. PubMed ID: 12181263
[TBL] [Abstract][Full Text] [Related]
11. The Muir-Torre syndrome: a rare variant of hereditary nonpolyposis colorectal cancer associated with hMSH2 mutation.
Suspiro A; Fidalgo P; Cravo M; Albuquerque C; Ramalho E; Leitão CN; Costa Mira F
Am J Gastroenterol; 1998 Sep; 93(9):1572-4. PubMed ID: 9732950
[TBL] [Abstract][Full Text] [Related]
12. [Muir-Torre syndrome].
Jonas J; Kruse R; Bähr R
Chirurg; 2002 Apr; 73(4):366-9. PubMed ID: 12063922
[TBL] [Abstract][Full Text] [Related]
13. Colorectal cancer and the Muir-Torre syndrome in a Gypsy family: a review.
Lynch HT; Leibowitz R; Smyrk T; Fusaro RM; Lynch JF; Smith A; Franklin B; Stella A; Liu B
Am J Gastroenterol; 1999 Mar; 94(3):575-80. PubMed ID: 10086635
[TBL] [Abstract][Full Text] [Related]
14. [Mutation in the MSH2 gene in Muir-Torre syndrome].
Godard V; Coulet F; Bernaudin JF; Housset M; Soubrier F
Ann Dermatol Venereol; 1999; 126(8-9):600-3. PubMed ID: 10530347
[TBL] [Abstract][Full Text] [Related]
15. Muir-Torre syndrome: Diagnostic and screening guidelines.
Jones B; Oh C; Mangold E; Egan CA
Australas J Dermatol; 2006 Nov; 47(4):266-9. PubMed ID: 17034469
[TBL] [Abstract][Full Text] [Related]
16. A Muir-Torre syndrome family.
Serleth HJ; Kisken WA
Am Surg; 1998 Apr; 64(4):365-9. PubMed ID: 9544152
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients.
Shin KH; Park YJ; Park JG
Clin Cancer Res; 2000 Feb; 6(2):536-40. PubMed ID: 10690536
[TBL] [Abstract][Full Text] [Related]
18. [Torre-Muir syndrome. Sebaceous gland tumors indicate colon carcinoma and other internal malignant tumors].
Karsten U; Christophers E; Sterry W
Dtsch Med Wochenschr; 1987 Aug; 112(34):1296-301. PubMed ID: 3622267
[TBL] [Abstract][Full Text] [Related]
19. All patients with sebaceous gland neoplasms should be screened for Muir-Torre syndrome.
Ingram JR; Griffiths AP; Roberts DL
Clin Exp Dermatol; 2009 Mar; 34(2):264-6. PubMed ID: 19187311
[No Abstract] [Full Text] [Related]
20. The importance of functional testing in the genetic assessment of Muir-Torre syndrome, a clinical subphenotype of HNPCC.
Ollila S; Fitzpatrick R; Sarantaus L; Kariola R; Ambus I; Velsher L; Hsieh E; Andersen MK; Raevaara TE; Gerdes AM; Mangold E; Peltomäki P; Lynch HT; Nyström M
Int J Oncol; 2006 Jan; 28(1):149-53. PubMed ID: 16327991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
